MIM
OMIC

Monashee Investment Management’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Monashee Investment Management’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,333
Closed -$1.1M – 398
2021
Q2 		$1.1M Buy
+1,333
New +$1.03M 0.13% 187

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
NIP
Nicholas Investment Partners Rancho Santa Fe, California $1.39B AUM 97.11% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Monashee Investment Management's OMIC Position: Q3 2021 in Review

Monashee Investment Management sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q3 2021, closing a stake of 1,333 shares — an estimated $1.1M sold.

Monashee Investment Management first reported a position in OMIC in Q2 2021 and held it in 1 quarter. The position peaked at $1.1M in Q2 2021. 52 funds tracked by Wall St. Rank hold OMIC as of Q3 2021.

  • Monashee Investment Management reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Monashee Investment Management sold 1,333 Singular Genomics Systems, Inc. Common Stock shares in Q3 2021, an estimated $1.1M.
  • Monashee Investment Management first reported a position in Singular Genomics Systems, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Monashee Investment Management's Singular Genomics Systems, Inc. Common Stock position peaked at $1.1M in Q2 2021.
  • 52 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q3 2021.

Based on Monashee Investment Management's 13F filing for Q3 2021, filed 9 Nov 2021.